Financial toxicity: a potential side effect of prostate cancer treatment among Australian men.
- Publisher:
- WILEY
- Publication Type:
- Journal Article
- Citation:
- Eur J Cancer Care (Engl), 2017, 26, (1)
- Issue Date:
- 2017-01
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Gordon, LG | |
dc.contributor.author | Walker, SM | |
dc.contributor.author | Mervin, MC | |
dc.contributor.author | Lowe, A | |
dc.contributor.author | Smith, DP | |
dc.contributor.author | Gardiner, RA | |
dc.contributor.author | Chambers, SK | |
dc.date.accessioned | 2022-10-03T05:10:42Z | |
dc.date.available | 2015-08-28 | |
dc.date.available | 2022-10-03T05:10:42Z | |
dc.date.issued | 2017-01 | |
dc.identifier.citation | Eur J Cancer Care (Engl), 2017, 26, (1) | |
dc.identifier.issn | 0961-5423 | |
dc.identifier.issn | 1365-2354 | |
dc.identifier.uri | http://hdl.handle.net/10453/162222 | |
dc.description.abstract | The purpose of this study was to understand the extent, nature and variability of the current economic burden of prostate cancer among Australian men. An online cross-sectional survey was developed that combined pre-existing economic measures and new questions. With few exceptions, the online survey was viable and acceptable to participants. The main outcomes were self-reported out-of-pocket costs of prostate cancer diagnosis and treatment, changes in employment status and household finances. Men were recruited from prostate cancer support groups throughout Australia. Descriptive statistical analyses were undertaken. A total of 289 men responded to the survey during April and June 2013. Our study found that men recently diagnosed (within 16 months of the survey) (n = 65) reported spending a median AU$8000 (interquartile range AU$14 000) for their cancer treatment while 75% of men spent up to AU$17 000 (2012). Twenty per cent of all men found the cost of treating their prostate cancer caused them 'a great deal' of distress. The findings suggest a large variability in medical costs for prostate cancer treatment with 5% of men spending $250 or less in out-of-pocket expenses and some men facing very high costs. On average, respondents in paid employment at diagnosis stated that they had retired 4-5 years earlier than planned. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | WILEY | |
dc.relation.ispartof | Eur J Cancer Care (Engl) | |
dc.relation.isbasedon | 10.1111/ecc.12392 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 1110 Nursing, 1112 Oncology and Carcinogenesis, 1117 Public Health and Health Services | |
dc.subject.classification | Oncology & Carcinogenesis | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Cost of Illness | |
dc.subject.mesh | Cross-Sectional Studies | |
dc.subject.mesh | Employment | |
dc.subject.mesh | Health Expenditures | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Prostatic Neoplasms | |
dc.subject.mesh | Retirement | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Prostatic Neoplasms | |
dc.subject.mesh | Retrospective Studies | |
dc.subject.mesh | Cross-Sectional Studies | |
dc.subject.mesh | Cost of Illness | |
dc.subject.mesh | Retirement | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Employment | |
dc.subject.mesh | Health Expenditures | |
dc.subject.mesh | Australia | |
dc.subject.mesh | Male | |
dc.title | Financial toxicity: a potential side effect of prostate cancer treatment among Australian men. | |
dc.type | Journal Article | |
utslib.citation.volume | 26 | |
utslib.location.activity | England | |
utslib.for | 1110 Nursing | |
utslib.for | 1112 Oncology and Carcinogenesis | |
utslib.for | 1117 Public Health and Health Services | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2022-10-03T05:10:40Z | |
pubs.issue | 1 | |
pubs.publication-status | Published | |
pubs.volume | 26 | |
utslib.citation.issue | 1 |
Abstract:
The purpose of this study was to understand the extent, nature and variability of the current economic burden of prostate cancer among Australian men. An online cross-sectional survey was developed that combined pre-existing economic measures and new questions. With few exceptions, the online survey was viable and acceptable to participants. The main outcomes were self-reported out-of-pocket costs of prostate cancer diagnosis and treatment, changes in employment status and household finances. Men were recruited from prostate cancer support groups throughout Australia. Descriptive statistical analyses were undertaken. A total of 289 men responded to the survey during April and June 2013. Our study found that men recently diagnosed (within 16 months of the survey) (n = 65) reported spending a median AU$8000 (interquartile range AU$14 000) for their cancer treatment while 75% of men spent up to AU$17 000 (2012). Twenty per cent of all men found the cost of treating their prostate cancer caused them 'a great deal' of distress. The findings suggest a large variability in medical costs for prostate cancer treatment with 5% of men spending $250 or less in out-of-pocket expenses and some men facing very high costs. On average, respondents in paid employment at diagnosis stated that they had retired 4-5 years earlier than planned.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph